US Broker Ratings

Alvotech (ALVO) Stock Analysis: Exploring a 421% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) is gaining investor attention with its ambitious portfolio in the healthcare sector, specifically within the drug manufacturers specializing in specialty and generic biosimilars. Based in Luxembourg, this..

Premier, Inc. (PINC) Stock Analysis: Stagnant Price and a Strong Dividend Yield in the Healthcare Sector

For investors keeping an eye on the healthcare sector, Premier, Inc. (NASDAQ: PINC) presents an intriguing case. With a market capitalization of $2.34 billion, Premier operates as a healthcare improvement..

UFP Technologies, Inc. (UFPT) Stock Analysis: Potential Upside of Nearly 60% Captivates Investors

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector specializing in medical devices, is generating significant buzz among investors with its impressive potential upside of nearly 60%..

Certara, Inc. (CERT) Stock Analysis: Unlocking a 41% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT), a leader in health information services, is presenting a potentially lucrative opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of $1.03..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring Growth Potential with 10.84% Upside

Twist Bioscience Corporation (NASDAQ: TWST), headquartered in South San Francisco, California, is a prominent player in the healthcare sector, specializing in the diagnostics and research industry. With a market capitalization..

Agios Pharmaceuticals (AGIO) Stock Analysis: Evaluating the 38% Upside Potential in Biotechnology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a pioneering biopharmaceutical company, stands at the forefront of cellular metabolism therapy. With a market capitalization of $1.69 billion, this Massachusetts-based biotech firm has garnered..

Warby Parker Inc. (WRBY) Stock Analysis: Exploring a 25% Upside Potential

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s niche of medical instruments and supplies, has carved out a distinct identity with its innovative approach to eyewear..

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook Highlights 123.98% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a formidable player in the biotechnology sector, dedicated to pioneering novel therapeutics for rare endocrine diseases and endocrine-related tumors. With a market capitalization of..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Look at Its 40% Upside Potential

Investors with a keen interest in the biotechnology sector should pay close attention to Centessa Pharmaceuticals plc (NASDAQ: CNTA). This clinical-stage pharmaceutical company, headquartered in Altrincham, United Kingdom, is making..

Select Medical Holdings Corpora (SEM)

⚠️ No article content returned.

..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Biotech Waves Post-Pfizer Acquisition

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology firm based in New York, is creating ripples in the healthcare sector with its innovative approaches to combat obesity and related diseases. Now..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 44% Upside Potential in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector focusing on diagnostics and research, presents a compelling opportunity for investors looking to tap into the burgeoning market for..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 37.66% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (NASDAQ: ARDT) has emerged as a notable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $1.32 billion, this..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A Closer Look at Its Valuation and Growth Potential

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands as a prominent player in the U.S. healthcare sector, specializing in providing a range of behavioral healthcare services. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 45.63% Potential Upside

For investors keen on the healthcare sector, Alignment Healthcare, Inc. (NASDAQ: ALHC) offers an intriguing opportunity with a significant potential upside of 45.63%. This California-based company operates a consumer-centric healthcare..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 64.5% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take a closer look at Immunovant, Inc. (NASDAQ: IMVT), a promising player in the burgeoning field of monoclonal antibodies for..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with a 27.89% Potential Upside

Belite Bio, Inc (BLTE), a dynamic player in the biotechnology sector, stands out as a promising investment opportunity, particularly for those interested in the cutting-edge field of retinal degenerative diseases...

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 109% Upside with Innovative Cancer Treatment Solutions

NovoCure Limited (NASDAQ: NVCR), a pioneering force in the medical device sector, is captivating investor attention with its innovative tumor treating fields (TTFields) technology. This Switzerland-based company, with a market..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unveiling a 38.92% Potential Upside Opportunity

Investors seeking opportunities in the healthcare sector should take a closer look at Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the medical care facilities industry. With a market..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Discover a 52.45% Potential Upside with Robust Revenue Growth

LifeStance Health Group, Inc. (NASDAQ: LFST) is setting a distinct tone in the healthcare sector, particularly within the medical care facilities industry, with its innovative approach to mental health services...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds